Trials / Completed
CompletedNCT03686384
SVT-15652 Otic Solution for the Treatment of Otomycosis
A Phase III, Multicenter, Randomized, Double-Blind Clinical Trial to Assess the Efficacy and Safety of SVT-15652 Otic Solution Compared to Placebo for the Treatment of Fungal Otitis Externa (Otomycosis)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 217 (actual)
- Sponsor
- Salvat · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Multicenter, randomized, 2-arm parallel-group, double blind, placebo-controlled study in patients suffering from Otomycosis. This study will compare the efficacy and safety of SVT-15652 otic solution to that of Placebo, when administering one vial twice daily during 14 days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SVT-15652 | 1 vial twice daily |
| DRUG | Placebo | 1 vial twice daily |
Timeline
- Start date
- 2020-02-27
- Primary completion
- 2021-10-25
- Completion
- 2021-10-25
- First posted
- 2018-09-26
- Last updated
- 2024-12-03
- Results posted
- 2023-01-18
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03686384. Inclusion in this directory is not an endorsement.